Cargando…
Fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties
BACKGROUND AND PURPOSE: Data on application of fast-track/enhanced recovery protocols in revision hip arthroplasty (R-THA) surgery is scarce. We report length of stay (LOS), risk of LOS > 5 days, and readmission ≤ 90 days after revision hip arthroplasty in centers with a well-established fast-tra...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Journals Sweden, on behalf of the Nordic Orthopedic Federation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865005/ https://www.ncbi.nlm.nih.gov/pubmed/35195270 http://dx.doi.org/10.2340/17453674.2022.2196 |
_version_ | 1784655567992651776 |
---|---|
author | LINDBERG-LARSEN, Martin PETERSEN, Pelle Baggesgaard CORAP, Yasemin GROMOV, Kirill JØRGENSEN, Christoffer Calov KEHLET, Henrik |
author_facet | LINDBERG-LARSEN, Martin PETERSEN, Pelle Baggesgaard CORAP, Yasemin GROMOV, Kirill JØRGENSEN, Christoffer Calov KEHLET, Henrik |
author_sort | LINDBERG-LARSEN, Martin |
collection | PubMed |
description | BACKGROUND AND PURPOSE: Data on application of fast-track/enhanced recovery protocols in revision hip arthroplasty (R-THA) surgery is scarce. We report length of stay (LOS), risk of LOS > 5 days, and readmission ≤ 90 days after revision hip arthroplasty in centers with a well-established fast-track protocol in both primary and revision procedures. PATIENTS AND METHODS: This is an observational cohort study from the Centre for Fast-track Hip and Knee Replacement and the Danish Hip Arthroplasty Register. Consecutive elective aseptic major component revision hip arthroplasties from 6 dedicated fast-track centers from 2010 to 2018 were included. RESULTS: 1,345 R-THAs were analyzed, including 23% total revisions, 52% acetabular component revisions, and 25% femoral component revisions. Mean age was 70 years (SD 12) and 61% were female. Median LOS was 3 days (interquartile range [IQR] 2–6), decreasing from median 6 (IQR 3–10) days in 2010 to 2 (IQR 1–4) days in 2018. The 90-day readmission rate was 20%, but showed a fluctuating and increasing trend from 13% in 2010 to 28% in 2018. Risk factors for LOS > 5 days and readmission were use of walking aid, preoperative hemoglobin ≤ 13 g/dL, pharmacological treated psychiatric disorder, age ≥ 80 years, age 70–79 years (only LOS > 5 days), cardiac disease (only LOS > 5 days), pulmonary disease (only readmission), BMI ≥ 35 (only LOS > 5 days) and ≥ 1 previous revision (only LOS > 5 days). INTERPRETATION: LOS decreased to median 2 days at the end of the study period, but the 90 days readmission risk remained high (> 20%). Several risk factors for postoperative complications were identified, suggesting that at-risk patients should be treated using an extended fast-track/enhanced recovery protocol focusing on preoperative optimization and postoperative monitoring as well as surgical techniques to reduce hip dislocations. |
format | Online Article Text |
id | pubmed-8865005 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Medical Journals Sweden, on behalf of the Nordic Orthopedic Federation |
record_format | MEDLINE/PubMed |
spelling | pubmed-88650052022-03-04 Fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties LINDBERG-LARSEN, Martin PETERSEN, Pelle Baggesgaard CORAP, Yasemin GROMOV, Kirill JØRGENSEN, Christoffer Calov KEHLET, Henrik Acta Orthop Article BACKGROUND AND PURPOSE: Data on application of fast-track/enhanced recovery protocols in revision hip arthroplasty (R-THA) surgery is scarce. We report length of stay (LOS), risk of LOS > 5 days, and readmission ≤ 90 days after revision hip arthroplasty in centers with a well-established fast-track protocol in both primary and revision procedures. PATIENTS AND METHODS: This is an observational cohort study from the Centre for Fast-track Hip and Knee Replacement and the Danish Hip Arthroplasty Register. Consecutive elective aseptic major component revision hip arthroplasties from 6 dedicated fast-track centers from 2010 to 2018 were included. RESULTS: 1,345 R-THAs were analyzed, including 23% total revisions, 52% acetabular component revisions, and 25% femoral component revisions. Mean age was 70 years (SD 12) and 61% were female. Median LOS was 3 days (interquartile range [IQR] 2–6), decreasing from median 6 (IQR 3–10) days in 2010 to 2 (IQR 1–4) days in 2018. The 90-day readmission rate was 20%, but showed a fluctuating and increasing trend from 13% in 2010 to 28% in 2018. Risk factors for LOS > 5 days and readmission were use of walking aid, preoperative hemoglobin ≤ 13 g/dL, pharmacological treated psychiatric disorder, age ≥ 80 years, age 70–79 years (only LOS > 5 days), cardiac disease (only LOS > 5 days), pulmonary disease (only readmission), BMI ≥ 35 (only LOS > 5 days) and ≥ 1 previous revision (only LOS > 5 days). INTERPRETATION: LOS decreased to median 2 days at the end of the study period, but the 90 days readmission risk remained high (> 20%). Several risk factors for postoperative complications were identified, suggesting that at-risk patients should be treated using an extended fast-track/enhanced recovery protocol focusing on preoperative optimization and postoperative monitoring as well as surgical techniques to reduce hip dislocations. Medical Journals Sweden, on behalf of the Nordic Orthopedic Federation 2022-02-23 /pmc/articles/PMC8865005/ /pubmed/35195270 http://dx.doi.org/10.2340/17453674.2022.2196 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work. |
spellingShingle | Article LINDBERG-LARSEN, Martin PETERSEN, Pelle Baggesgaard CORAP, Yasemin GROMOV, Kirill JØRGENSEN, Christoffer Calov KEHLET, Henrik Fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties |
title | Fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties |
title_full | Fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties |
title_fullStr | Fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties |
title_full_unstemmed | Fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties |
title_short | Fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties |
title_sort | fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865005/ https://www.ncbi.nlm.nih.gov/pubmed/35195270 http://dx.doi.org/10.2340/17453674.2022.2196 |
work_keys_str_mv | AT lindberglarsenmartin fasttrackrevisionhiparthroplastyamulticentercohortstudyon1345electiveasepticmajorcomponentrevisionhiparthroplasties AT petersenpellebaggesgaard fasttrackrevisionhiparthroplastyamulticentercohortstudyon1345electiveasepticmajorcomponentrevisionhiparthroplasties AT corapyasemin fasttrackrevisionhiparthroplastyamulticentercohortstudyon1345electiveasepticmajorcomponentrevisionhiparthroplasties AT gromovkirill fasttrackrevisionhiparthroplastyamulticentercohortstudyon1345electiveasepticmajorcomponentrevisionhiparthroplasties AT jørgensenchristoffercalov fasttrackrevisionhiparthroplastyamulticentercohortstudyon1345electiveasepticmajorcomponentrevisionhiparthroplasties AT kehlethenrik fasttrackrevisionhiparthroplastyamulticentercohortstudyon1345electiveasepticmajorcomponentrevisionhiparthroplasties |